Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv
Breif interview of my progress with Multiple Sclerosis with Adult Stem Cell therapy after my experience with Tysabri, Gilenya and Ampira failed.From:MSajourneyfromwithinViews:1 0ratingsTime:04:21More inEducation

View post:
Video 7 - November 14, 2012 - Adult Stem Cells Progress.wmv - Video

Recommendation and review posted by Bethany Smith

Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v
http://www.newininstitute.com.au PRP Therapy was chosen instead of a Hair Transplant to treat an area of hair loss in a female. 2 month comparison Before and After photos show a highly successful outcome. Note that continued hair growth will occur over the coming months. Another procedure will need to be performed at around the peak period: 12-18 months when growth begins to slow. Newin Institute has uniquely developed processes and protocols for PRP and Adipose Stem Cell Therapy.From:Rhett BosnichViews:0 0ratingsTime:00:55More inScience Technology

Read the original post:
Hair Loss PRP-Stem Cell Therapy-2 month comparison- Large.m4v - Video

Recommendation and review posted by Bethany Smith

What Are Stem Cells and Stem Cell Therapy Stemenhance
http://www.stemcellproduct.net This video gives you the definition, facts, and understanding on what are stem cells, that there are two of them embryonic and adult stem cells, how they work and the uses of stem cell when the tissue is affected in your body and how messengers signal the bone marrow to release adult stem cells to help in the repair of the injured tissue. Why this information is exciting for me to do a video is because I see stemcells as the best way of how to produce optimal health in your body. The way I look at it is that optimal health equals the number of healthy cells in your body and the only way the body repairs a damaged area is by creating and sending adult stem cells to that area. That #39;s why I #39;m introducing a stem cell product from a nutrition company who patented a stem cell enhancer which supports the release of adult stem cells. What will also excite you too is that Stemtech (the stemcell company) has also come out with two other products that will also optimize the circulation of these stem cells and other nutrients and aid in the ability for them to move and migrate into the affected tissue where they can transform and duplicate into fresh, healthy new cell tissue. So in my eyes having products like these will help anyone in my pursuit of health and wellness. I know it #39;s helping me strengthening my cells in my body after being diagnosed with chronic fatigue syndrome 20 plus years ago because I know how important nutrition and cell help to gain my ...From:Jennifer MarksViews:1 0ratingsTime:06:37More inHowto Style

See the original post:
What Are Stem Cells and Stem Cell Therapy Stemenhance - Video

Recommendation and review posted by Bethany Smith

ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer - Qiao Ling
http://www.zell-v.com We specialise in cell therapy products for anti aging. we are supported by an international medical board of practitioners, biologist and wellness professionals.From:zellvsheepplacentaViews:5 0ratingsTime:01:56More inHowto Style

Continue reading here:
ZÉLL-V Sheep Placenta Anti Aging Satisfied Customer - Qiao Ling - Video

Recommendation and review posted by Bethany Smith

SAN DIEGO, CA--(Marketwire - Nov 19, 2012) - Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) announced today that its wholly owned subsidiary, Regen BioPharma, Inc., has contracted Cascade Life Sciences, Inc. to research the safety and efficacy of Regen's HemaXellerate product usingmice models for testing.Cascade Life Sciences is a privately-owned San Diego-based company with a platform of stem cell related technologies that are being advanced to serve the research community and the commercial development of stem cell-based therapeutics. Sophia Khaldoyanidi, M.D., Ph.D. is the principal investigator of the study.

The results of Regen's study will provide the safety profile data required for filing of anInvestigational New Drug (IND) application for the product with the US Food and Drug Administration .Regen intends to file an IND Application in the fourth quarter of 2012 and conduct Phase I/II clinical trials during 2013 and 2014.

HemaXellerate offers the possibility of delivering a population of endothelial cells to restore blood production in patients with hematological conditions."Unlike current approaches of administering pharmaceuticals," said J. Christopher Mizer, President of Regen BioPharma, "our strategy is to heal the bone marrow by administering cells that provide the optimum mix of growth factors to stimulate the bone marrow into producing blood cells naturally."

Regen has submitted two provisional patent applications covering the use of different sources of endothelial cells to heal damaged bone marrow. These applications cover: (1) placental cells (61/648898 - Acceleration 0f Hematopoietic Reconstitution by Placental Endothelial and Endothelial Progenitor Cells); and (2) fat cells (61/670791 - Treatment of Hematopoietic Disorders).

About Bio-Matrix Scientific Group Inc. and Regen BioPharma, Inc.:

Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ) is a biotechnology company developing regenerative medicine therapies. The Company is focused on human therapies that address unmet medical needs. Specifically, Bio-Matrix Scientific Group Inc. is looking to increase the quality of life through therapies involving stem cell treatments. These treatments are focused in areas relating to cardiovascular, hematology, oncology and other indications.

Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. ( OTCQB : BMSN ), is a biotechnology company focused on identifying undervalued regenerative medicine patents in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. To follow our development, visit us at http://www.regenbiopharma.com.

Disclaimer

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks

Read the original:
Bio-Matrix' Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate(TM) Cell Therapy

Recommendation and review posted by Bethany Smith

The Irish Times - Monday, November 19, 2012

CLAIRE O'CONNELL

Could a particular type of adult stem cell offer a useful therapy for diabetes? An EU-funded project being led by NUI Galway hopes to find out.

The 6 million Reddstar project will assess whether the stem cells can tackle glucose levels and various complications of diabetes, including diabetic ulcers and eye, nerve, heart and kidney and bone damage.

The approach centres on a specific adult stem-cell population owned by Orbsen Therapeutics, a spin-out from the Science Foundation Ireland-funded Regenerative Medicine Institute (Remedi) at NUI Galway.

Initially, the project will develop ways to grow the bone-marrow-derived stem cells in a way that is useful for trials, according to company co-founder and Remedi director Prof Tim OBrien.

The cells will then be tested in several preclinical models of diabetic complications at centres in Galway, Belfast, Munich, Berlin and Porto.

Then the plan is to select one complication for which the adult stem cells will be assessed in human trials in Denmark.

The three-year EU funding will support nine jobs in Ireland, five of which will be in Orbsen Therapeutics, according to CEO Brian Molloy, who says the project should help to build Irelands status as a hub for cell therapy development and commercialisation.

Whilst wins such as the Reddstar programme are fantastic for us, we need to continue to develop and advance our product, he says.

Visit link:
NUI Galway to lead €6m research project into stem cell therapy for diabetes

Recommendation and review posted by Bethany Smith

For Dr. Robert Janson-Mller, the science of fresh cell therapy is in his blood.

His grandfather, Dr. Philipp Janson was one of the few doctors who introduced the treatment in Germany. His father, Dr. Wolfgang Janson-Mller continued the work that was eventually passed on to him.

He was exposed to the revolutionary world of fresh cell therapy early on in life. The treatment uses live young cells from a donor animal like sheep to help regenerate damaged cells in the body. Dr. Mller practically grew up in his grandfather and father's clinic where he met the former's patients, some of whom still go to him for their regular treatments.

''A child always wants to grow up like his father and do the same thing. My father left it open for me. He told me I could do whatever I want, the same thing I am doing now for my daughter. I'm also head of a clinic in Munich. This is what I do besides cell treatment. We have a family practice. That is my main job,'' shares the 46-year-old German doctor who recently visited the Philippines to acquaint Filipinos with the science of fresh cell therapy.

Dr. Mller, who owns a fresh cell therapy laboratory and works as head doctor of Med Activ clinic in Munich, says that despite the growing market for it in America and Asia, there are only five doctors in Germany practicing the science. The treatment is known to deter degenerative diseases such as arthrosis, rheumatism and neurological disorders such as multiple sclerosis. But it is most popular as an anti-aging treatment. Recently, it has also been used to treat children with autism and Down syndrome.

Yet, Dr. Mller points out that fresh cell therapy is not a miracle cure for aging or these diseases. Some bodies accept the treatment while some don't. And, it doesn't treat every disease known to mankind.

Nevertheless, patients from all over the world still flock to his private clinic at the Prinzregent Hotel in Edenkoben, Germany to avail themselves of the treatment, which does not come cheap. One session would cost about $12,000 or R624,000.

''I don't treat patients with cancer, tuberculosis, AIDS, or those who are pregnant. We don't treat patients with acute inflammations like appendicitis. Aside from that, I need to see if it makes sense. If I don't see a possibility, I say no,'' he explains.

In this 60 Minutes interview, Dr. Mller shares how fresh cell therapy really works and how it can take more than just one, two, 20, 60 or even 100 treatments to get it right. Some may start as young as eight months old or continue the treatment at 99 years old. This just proves that a patient is never too young nor too old for this revolutionary treatment. (Angelo G. Garcia)

STUDENTS AND CAMPUSES BULLETIN (SCB): A lot of people are confused about the difference between stem cell and fresh cell therapy.

Read the original post:
The cell therapist

Recommendation and review posted by Bethany Smith

Icelandic genetic research company deCODE together with scientists from the Landsptali National University Hospital of Iceland and researchers in Holland, Germany and the United States have discovered a second gene variant to confer a high risk of acquiring the more common, late-onset of Alzheimers disease.

The variant was also found to predict poorer cognitive function in older individuals who do not have Alzheimers disease. The results of the research were published in the New English Journal of Medicine on Wednesday.

According to CEO of deCODE and lead author Kri Stefnsson, the results will provide new focus for drug development. The discovery of variant TREM2 is important because it confers high risk for Alzheimers and because the genes normal biological function has been shown to reduce immune response that may contribute to the disease. These combined factors make TREM2 an attractive target for drug development, he said.

The researchers obtained the genome sequences of 2,261 Icelanders and identified sequence variants that were likely to affect protein function.

ZR

Original post:
Icelandic Genetic Research Company Find Alzheimer’s Gene Variant

Recommendation and review posted by Bethany Smith

Genetic Engineering Controversy HD
A presentation on genetic modification for our freshmen seminar at Penn State University. We discuss the issues and facts surrounding the controversy about genetically modified foods, animals, and plants.From:Benjamin FowlerViews:11 0ratingsTime:33:07More inScience Technology

Read the original post:
Genetic Engineering Controversy HD - Video

Recommendation and review posted by Bethany Smith

Transformers: Beast Wars Classic Deluxe Rhinox Action Figure
Special Price Link: http://www.demizzy.com Beast Wars Rhinox Action Figure Bio-genetic engineering has allowed the Transformers to create a perfect cybernetic fusion between ferocious animals and mechanical technology. The result: heroic Maximals vs. evil Predacons! Robot warriors disguised as wild animals in an explosive fight to the finish the Beast Wars have begun! Hasbro produced this line of action figures based on the animated hit. Beast Wars. Heroic Maximal Rhinox transforms from Defense Robot to Rhino and back and features SpinFrom:KieraARogerswViews:0 0ratingsTime:00:50More inPeople Blogs

Read more:
Transformers: Beast Wars Classic Deluxe Rhinox Action Figure - Video

Recommendation and review posted by Bethany Smith

Biology: Understanding Genetic Engineering
From Advanced Listening Comprehension Third EditionFrom:GeneJarvisViews:2 0ratingsTime:10:01More inPeople Blogs

Read the rest here:
Biology: Understanding Genetic Engineering - Video

Recommendation and review posted by Bethany Smith

GMO babies now being engineered in labs
A genetically modified organism (GMO) is an organism whose genetic material has been altered using genetic engineering techniques. GMO babies now being engineered in labsFrom:extremumspiritumViews:0 0ratingsTime:01:10More inNews Politics

See the original post:
GMO babies now being engineered in labs - Video

Recommendation and review posted by Bethany Smith

Fields of (un)certainty: some issues of genetic engineering in agriculture
A talk by Benson Issac, faculty, Azim Premji University at Azim Premji University September 26, 2012 About the Topic Debates around scientific, social, economic and environmental risk and uncertainities have been an integral part of the controversy around the introduction of GMOs in agriculture in India. After Bt cotton - the first crop that was cleared for commercial cultivation, all proposed genetically modified food crops have been stopped from receiving clearances at various stages of the regulatory process. The talk will discuss these uncertainties and the various stakeholder positions -- from organic farmers to corporations and the government. The talk will foreground the proposed changes to be introduced by the BRAI bill and the implications it has on the regulatory system, centre-state relations and linked issues of environmental governance and agricultural policy. About the Speaker Benson Issac , has been with the Azim Premji Univeristy for over a year. He is interested in issues of alternative livelihoods that bring together the agency of young people and their world of work, traditional skills, issues of social and economic sustainability. He is involved closely with a group of young organic farmers from around Bangalore Rural District. He is keenly interested in issues of traditional artisans and is exploring ways of working with them, that will look at artisans as not merely producers seeking a market but people with alternative worldviews and knowledge ...From:AzimPremjiUniversityViews:0 0ratingsTime:01:28:25More inScience Technology

Read the rest here:
Fields of (un)certainty: some issues of genetic engineering in agriculture - Video

Recommendation and review posted by Bethany Smith

Inside Out By Cory Quirino Philippine Daily Inquirer

(Part I)

Confusion rules the day if you read up on too many approaches to living the wellness lifestyle, especially if the topic is dieting. The result: information overload. There are no fast and easy answers. Regarding your wellness issues, here are answers to some of your questions.

Q: Heart disease runs in the family, and I fear the same fate as my fathers. What should I do?

While genetics plays a major role in your predisposition toward certain illnesses, positive lifestyle changes have the power to alter 50 percent of your outlook. So, fear not. You are not doomed to your genetic fate. Especially if you are taking charge of your health today.

To do:

1. See your cardiologist, nutritionist, fitness trainer.

2. Make immediate changes in your habits, especially if you have many bad ones, like drinking alcohol, smoking, not exercising and others.

We have all heard stories about people in their early 40s who are careful with their diets and exercise regularly yet suffer sudden heart attacks. Doctors have known that a healthy lifestyle can prevent heart disease. However, it has been discovered that a lack of certain nutrients can lead to heart problems.

There is the Nurses Health Study being conducted at Harvard Medical School, and Brigham and Womens Hospital in Boston. After following over 73,000 nurses, it was found that a diet rich in vitamin E reduced heart attack risk by 52 percent; vitamin C reduced risk of 43 percent and betacarotene reduced risk by 38 percent. These nutrients protect your arteries. The other nutrients are CoQ10 and selenium which nutrition-oriented doctors recommend. Garlic has been used for centuries to clean up the blood and the heart. Studies indicate that eating one clove of fresh garlic daily can significantly lower total cholesterol. If you develop indigestion, consider garlic oil capsules taken during meals.

Read the original post:
You are not doomed to your genetic fate

Recommendation and review posted by Bethany Smith

Genetic differences identified in children with sagittal craniosynostosis.

Sacramento, Calif. (PRWEB) November 18, 2012

"We have discovered two genetic factors that are strongly associated with the most common form of premature closure of the skull," said Simeon Boyadjiev, professor of pediatrics and genetics, principal investigator for the study and leader of the International Craniosynostosis Consortium.

"These findings may one day lead to prenatal screening and diagnostic tests for this condition or early interventions to prevent it," said Boyadjiev, who is a researcher affiliated with the UC Davis MIND Institute.

The study, "A genome-wide association study identifies susceptibility loci for non-syndromic sagittal craniosynostosis near BMP2 and within BBS9," is published online today in the journal, Nature Genetics.

During fetal and early child development, the skull is made of separate bony plates that allow for growth of the head. The borders between the plates do not normally fuse completely until a child is about 2 years old, leaving temporary "soft spots" at the intersection of the seams.

If the bones fuse too early the condition called craniosynostosis a child will develop an abnormally shaped head. Left untreated, the disorder causes complications due to brain compression, such as neurologic and visual problems and learning disabilities. Typically, craniosynostosis requires extensive neurosurgical correction.

About 20 percent of cases of craniosynostosis have previously been linked to a number of different genetic syndromes, but the vast majority of cases (not associated with a syndrome involving other birth defects) arise without any known family history or cause. The most common form of non-syndromic craniosynostosis affecting about 1 in 5,000 newborns involves the sagittal suture, the main seam that runs down the center of the top of the skull. These cases were the subject of the investigation.

Although the condition has long been thought to be partially determined by genes it is three times more common in boys than in girls, and identical twins are much more likely to both be affected than non-identical twins the exact basis was unclear.

To help determine the cause, the investigators conducted the first genome-wide association study for the disorder, which involves scanning the entire genome of a group of people with craniosynostosis and comparing it to a control group of people without the condition. The study searched for single nucleotide polymorphisms (abbreviated as SNPs and called "snips") that are associated with craniosynostosis. SNPs are DNA changes in which a single nucleotide differs from the usual one at that position. There are some three billion nucleotides, the basic building blocks of DNA, in the human genome.

Read the original:
UC Davis Researchers Find Likely Genetic Basis of Premature Skull Closure in Infants

Recommendation and review posted by Bethany Smith

Researchers at Mount Sinai School of Medicine have validated new genetic links for sagittal craniosynostosis, a common birth defect in which the bones that form the sides and top of the skull, fuse prematurely.

New York, NY (PRWEB) November 18, 2012

Craniosynostosis is one of the ten most common birth defects, occurring in about 1 out of every 2,500 live births. The sagittal form of craniosynostosis, which impedes growth of the skull so that the shape becomes elongated, occurs in about half the cases, or 1 in 5,000 live births. Unless it is treated surgically to release pressure on the brain within the first year of life, it interferes with brain growth causing neurologic deficits. Non-syndromic sagittal craniosynostosis is not associated with other abnormalities.

Until now, efforts to improve the health outcomes of infants born with sagittal craniosynostosis have been limited to surgery performed by neurosurgical and plastic surgery teams. But researchers have been focusing on the contribution of genetics, as well as environmental triggers.

To investigate the genetic associations, the International Craniosynostosis Consortium studied 130 trios (the affected child and both parents). Very strong associations for genetic markers near the BMP2 [bone morphogenetic protein] gene on chromosome 7 and also within the BBS9 [Bardet-Biedel syndrome 9] gene on chromosome 20 were found, and we replicated it with 172 cases and 548 controls said Ethylin Wang Jabs, MD, PhD, Professor of Genetics and Genomic Sciences, Developmental and Regenerative Biology, and Pediatrics at Mount Sinai School of Medicine. This association suggests that individuals carrying these genetic markers may have more than a four-fold risk of having sagittal craniosynostosis, added Inga Peter, PhD, Associate Professor of Genetics and Genomic Sciences. To find so much power, this is a big breakthrough.

The findings open the door to more genetic research. Investigators will pursue sequencing studies, perhaps finding other loci and genes of interest, Dr. Jabs added.

Other Mount Sinai coauthors include Monica Erazo, Xiaoqian Ye, Edmond Ainehsazan, Lisong Shi, and Peter J. Taub.

The National Institutes of Health and Centers for Disease Control and Prevention supported this research. Genotyping was performed at the Center for Inherited Disease Research at the National Institutes of Health. Participants were recruited and evaluated through the collaborative effort of the International Craniosynostosis Consortium.

One of the first of its kind in the New York area, Mount Sinais Congenital Anomalies and Craniofacial Program led by Dr. Jabs has been at the forefront of genetics and clinical research in congenital abnormalities, especially those of the head, neck, and limbs. Patients are seen by clinical geneticists that are experts in dysmorphology as well as by the Craniofacial and Cleft Clinic with a multidisciplinary team of geneticists, pediatricians, speech therapists, dentists, otolaryngologists, plastic surgery, maxillofacial surgeons, neurosurgery, and ophthalmologists, co-directed by Drs. Lester Silver and Peter Taub. The research focus of Dr. Jabs' laboratory at Mount Sinai has been to increase our understanding of the molecular basis of human malformation disorders and to develop new preventive and therapeutic interventions.

About The Mount Sinai Medical Center

Read more:
Common Cranial Birth Defect: Mount Sinai Researchers Validate Genetic Links

Recommendation and review posted by Bethany Smith

Public release date: 18-Nov-2012 [ | E-mail | Share ]

Contact: Karen N. Peart karen.peart@yale.edu 203-432-1326 Yale University

The prevailing wisdom has been that every cell in the body contains identical DNA. However, a new study of stem cells derived from the skin has found that genetic variations are widespread in the body's tissues, a finding with profound implications for genetic screening, according to Yale School of Medicine researchers.

Published in the Nov. 18 issue of Nature, the study paves the way for assessing the extent of gene variation, and for better understanding human development and disease.

"We found that humans are made up of a mosaic of cells with different genomes," said lead author Flora Vaccarino, M.D., the Harris Professor of Child Psychiatry at the Yale Child Study Center. "We saw that 30 percent of skin cells harbor copy number variations (CNV), which are segments of DNA that are deleted or duplicated. Previously it was assumed that these variations only occurred in cases of disease, such as cancer. The mosaic that we've seen in the skin could also be found in the blood, in the brain, and in other parts of the human body."

The longstanding belief has been that our cells have the same DNA sequence and this blueprint governs the body's functions. The Yale team's research challenges this dogma. Some scientists have hypothesized that during development, when DNA is copied from mother to daughter cells, there could be deletions, duplications and changes in the sequence of the DNA, and an entire group of genes could be affected. This premise has been incredibly difficult to test, but Vaccarino and colleagues have done so in this new study.

The team used whole genome sequencing to study induced pluripotent stem cells lines (iPS), which are stem cells developed from a mature-differentiated cell. The team grew cells taken from the inner upper arms of two families. The team spent two years characterizing these iPS cell lines and comparing them to the original skin cells.

While observing that the genome of iPS cells closely resembles the genome of skin cells from which they originated, the team could identify several deletions or duplications involving thousands of base pairs of DNA. The team then performed additional experiments to understand the origin of those differences, and showed that at least half of them pre-existed in small fractions of skin cells. These differences were revealed in iPS cells because each iPS line is derived from one, or very few, skin cells. Vaccarino said these iPS lines could act as a magnifying glass to see the mosaic of genomic differences in the body's cells.

"In the skin, this mosaicism is extensive and at least 30 percent of skin cells harbor different deletion or duplication of DNA, each found in a small percentage of cells," said Vaccarino. "The observation of somatic mosaicism has far-reaching consequences for genetic analyses, which currently use only blood samples. When we look at the blood DNA, it's not exactly reflecting the DNA of other tissues such as the brain. There could be mutations that we're missing."

"These findings are shaping our future studies, and we're doing more studies of the developing brains of animals and humans to see if this variation exists there as well," Vaccarino added.

Read the rest here:
Skin cells reveal DNA's genetic mosaic

Recommendation and review posted by Bethany Smith

November 19, 2012

redOrbit Staff & Wire Reports Your Universe Online

A new study of stem cells derived from skin tissue has challenged the commonly held notion that a persons cells all share the same DNA sequence, arguing instead that genetic variation may occur to a greater extent than experts had previously believed.

Researchers at the Yale School of Medicine set out to challenge the theory that human cells are comprised of identical genetic material, and that a bodys functions are governed by that blueprint. They set out to test a competing hypothesis that as DNA is copied from mother to daughter cells, deletions, duplications, and alternations to the sequence of the DNA could occur, and could affect entire groups of genes.

According to the university, that notion has been incredibly difficult to test, but Dr. Flora Vaccarino, a professor of child psychology at Yale, and colleagues did so by using whole genome sequencing to analyze induced pluripotent stem cells (iPS) taken from the upper, inner arms of a pair of different families.

They spent 24 months characterizing those iPS cell lines and comparing them to the skin cells from which they originated, and while the genomes of each cell group were similar, Dr. Vaccarinos team was able to pinpoint multiple deletions or duplications that involved thousands of base pairs of DNA, the university explained.

Additional research showed that at least half of the variations they observed pre-existed in a small percentage of skin cells. Those differences were noticeable in the iPS cells because each line of those stem cells originated from either a single or an extremely limited number of skin cells.

We found that humans are made up of a mosaic of cells with different genomes, Dr Vaccarino said in a statement. We saw that 30 percent of skin cells harbor copy number variations (CNV), which are segments of DNA that are deleted or duplicated. Previously it was assumed that these variations only occurred in cases of disease, such as cancer. The mosaic that weve seen in the skin could also be found in the blood, in the brain, and in other parts of the human body.

In the skin, this mosaicism is extensive and at least 30 percent of skin cells harbor different deletion or duplication of DNA, each found in a small percentage of cells, she added. The observation of somatic mosaicism has far-reaching consequences for genetic analyses, which currently use only blood samples. When we look at the blood DNA, its not exactly reflecting the DNA of other tissues such as the brain. There could be mutations that were missing.

Vaccarinos team, which also included fellow researchers Mark Gerstein, Sherman Weissman, Alexander Eckehart Urban, Alexej Abyzov, Jessica Mariani, Dean Palejev, Ying Zhang, Michael Seamus Haney, Livia Tomasini, Anthony Ferrandino, Lior A. Rosenberg Belmaker, Anna Szekely, Michael Wilson, Arif Kocabas, Nathaniel E. Calixto, Elena L. Grigorenko, Anita Huttner, and Katarzyna Chawarska, published their findings in Sundays edition of the journal Nature.

Link:
Study Reveals Genetic Variations Occur At The Cellular Level

Recommendation and review posted by Bethany Smith

McCabe Genetics 1071
From:Flinton McCabeViews:0 0ratingsTime:00:28More inPets Animals

Excerpt from:
McCabe Genetics 1071 - Video

Recommendation and review posted by Bethany Smith

McCabe Genetics 164
From:Flinton McCabeViews:0 0ratingsTime:00:22More inPets Animals

Continue reading here:
McCabe Genetics 164 - Video

Recommendation and review posted by Bethany Smith

Genetics of Bipolar Disorder - Recovery May Be Possible
Bipolarecovery.wordpress.com This is a presentation on genetic causes for bipolar disorder from the standpoint of the bipolar individual who wishes to recover. Unfortunately, genetic causes would likely be incurable. However, such causes are currently only "beliefs", not "facts". Thus, it is logical to conclude that recovery may be possible. The goal of this video is to show that there is still hope for those who wish to fully recover from bipolar disorder. If there are no genetic causes, then this so-called illness may actually be something that can be cured.From:IanReynirViews:1 1ratingsTime:07:52More inEducation

More here:
Genetics of Bipolar Disorder - Recovery May Be Possible - Video

Recommendation and review posted by Bethany Smith

The Reason I #39;ve Been Gone
Hey friends ... Not long ago the Alf got his home broken into.. Everything was lost and I haven #39;t had the heart to post a video, but I got love for all my great friends out there.. So this is the reason I #39;ve been away.. We got a small bit of life found from outside. Update to follow.. In life friends, you #39;ll have bad people flock to good hearted souls, especially if your a caregiver.. Sucks people can #39;t just ask for help they have to thief and take parts of people #39;s life #39;s they will never get back.. 10 years of genetics collected gone in a moment.. And most likely in a trash pile someplace, cause it didn #39;t mean a damn thing to them.. Sorry for the rant.. But just feel comfortable enough to share with ya.. Stay green AlfFrom:PlanetGreenToeViews:16 1ratingsTime:00:52More inEducation

The rest is here:
The Reason I've Been Gone - Video

Recommendation and review posted by Bethany Smith

Lysenkoism - Wiki Article
Lysenkoism, or Lysenko-Michurinism was the centralized political control exercised over genetics and agriculture by Trofim Lysenko and his followers. Lysenko was the director of the Soviet Lenin All-... Lysenkoism - Wiki Article - wikiplays.org Original @ http All Information Derived from Wikipedia using Creative Commons License: en.wikipedia.org Author: Duncharris Image URL: en.wikipedia.org ( This work is in the Public Domain. )From:WikiPlaysViews:0 0ratingsTime:15:26More inEducation

Originally posted here:
Lysenkoism - Wiki Article - Video

Recommendation and review posted by Bethany Smith

New geneticS
Runnin Humboldt seed org #39;s Blue Dream and Sour Diesel #2. TGA #39;s Dairy Queen, THSeeds Darkstar. Also phono hunting seven different Mr. Nice females...(Sensi Seeds) should be good! 1080p sorry for the blinding HPS, picking up some Method 7s asap In compliance with my states medical mmj laws. All legal medicineFrom:TheRealLuMpKiNgViews:9 4ratingsTime:08:26More inNonprofits Activism

The rest is here:
New geneticS - Video

Recommendation and review posted by Bethany Smith

Luna Genetics - Spinal Fluids
Psy-trance track I made around 2003-04.From:acidperplexerViews:0 0ratingsTime:03:32More inMusic

Read the original here:
Luna Genetics - Spinal Fluids - Video

Recommendation and review posted by Bethany Smith